If you’ve just been prescribed something for a herpes outbreak, the valacyclovir vs acyclovir question is probably the first thing you Googled. Both drugs treat the same viruses. Both have been around for decades. So why does one cost more, and does that extra cost actually buy you anything?
The short answer is yes, sort of, but not in the way most people assume. It’s less about which drug is "stronger" and more about how your body handles each one, and how many pills you’re willing to take in a day.
Here’s what actually matters when your prescriber writes one over the other, based on how the FDA labels each drug and what clinical practice looks like day-to-day.
How Valacyclovir and Acyclovir Actually Work
Both are antiviral drugs in the same family. They work by blocking an enzyme (viral DNA polymerase) that herpes simplex virus, or HSV, needs to copy itself. No copying, no spreading outbreak.
Acyclovir was the original, approved back in 1982. Valacyclovir came later as a prodrug of acyclovir. That’s the key detail. When you swallow valacyclovir, your liver converts it into acyclovir. So chemically, once inside you, they end up as the same active molecule doing the same job.
The difference is absorption. Only about 10 to 20% of oral acyclovir gets into your bloodstream. Valacyclovir? Roughly 55%, according to pharmacology data cited by the NIH. That’s a three to five times bump in bioavailability, which is why the dosing schedules look so different.
Valacyclovir vs Acyclovir on Dosing
This is where most patients feel the real difference.
For a first genital herpes episode, typical regimens look roughly like this (your prescriber will confirm the right dose for you):
- Acyclovir: 400 mg by mouth, three to five times a day, for 7 to 10 days
- Valacyclovir: 1 gram by mouth, twice daily, for 7 to 10 days
For recurrent outbreaks or daily suppression, valacyclovir often drops to once a day. Acyclovir stays at two to five times a day.
If you’ve ever tried to remember a pill five times a day while working, parenting, and sleeping, you already know why adherence data favors valacyclovir. Fewer doses, fewer missed pills, better viral suppression. The CDC’s STI treatment guidelines list both as first-line and treat them as clinically equivalent, but they note valacyclovir’s convenience advantage.
Do They Work Equally Well?
Head-to-head, the effectiveness is close enough that most guidelines call them interchangeable for uncomplicated HSV-1 and HSV-2. A 2003 study in the Journal of the American Academy of Dermatology compared the two for recurrent genital herpes and found similar healing times and symptom relief.
Where valacyclovir edges ahead:
- Transmission reduction. A landmark NEJM trial showed once-daily valacyclovir cut the risk of transmitting HSV-2 to a susceptible partner by about 48%. Acyclovir has less robust transmission data.
- Shingles (herpes zoster). Valacyclovir tends to produce higher plasma levels needed to treat zoster efficiently. For a deeper look at that specific use, our comparison of acyclovir vs Valtrex for shingles outbreaks breaks it down.
- Cold sores. Valacyclovir can shorten a cold sore episode with just one or two doses in some regimens, versus five days of acyclovir. If cold sores are your main concern, this side-by-side of acyclovir, valacyclovir, and Denavir for cold sores covers the practical differences.
For a straightforward first outbreak or occasional recurrence in an otherwise healthy adult, both work. In practice, the reason clinicians reach for valacyclovir more often now is simpler dosing and slightly better data on partner protection.
Side Effects and Safety
The safety profiles are remarkably similar because, remember, valacyclovir becomes acyclovir in your body.
Common side effects for both:
- Headache (the most reported, roughly 15% of users)
- Nausea
- Abdominal pain
- Dizziness or fatigue
Rare but serious concerns:
- Acute kidney injury, especially with dehydration or high IV doses
- Neurologic effects (confusion, hallucinations) in older adults or people with kidney impairment
- Thrombotic thrombocytopenic purpura, reported very rarely at high valacyclovir doses in immunocompromised patients
If you have reduced kidney function, your prescriber will likely lower the dose of either drug. MedlinePlus’s monograph is a good plain-language resource for the full side-effect picture. Staying well hydrated during treatment is one of the simplest ways to reduce kidney-related risk.
Cost and Convenience
Both drugs are available as generics, which has narrowed the price gap considerably. Generic acyclovir is typically the cheapest option, sometimes just a few dollars for a course with a discount card. Generic valacyclovir costs more, but with coupons or a cash-pay pharmacy, a 10-day course is often under $30. Compare prices on generic valacyclovir at edrugstore.com to see current pricing before you fill.
The real cost isn’t always the sticker price. If you skip doses of acyclovir because five-times-a-day is unrealistic for your schedule, the "cheaper" drug becomes the less effective one. That’s the honest tradeoff.
Which One Should You Ask For?
Here’s how the decision usually shakes out in practice:
- Choose acyclovir if: cost is a serious concern, you don’t mind frequent dosing, and you’re treating an uncomplicated first or recurrent HSV episode.
- Choose valacyclovir if: you want fewer pills per day, you’re on daily suppressive therapy, you’re trying to reduce transmission risk to a partner, or you’re treating shingles or cold sores.
Herpes management is more than just picking a pill, though. Understanding transmission patterns, triggers, and long-term suppression matters just as much. Our gentleman’s guide to genital herpes walks through the bigger picture, and if you’re still figuring out whether what you have is HSV at all, this piece on whether cold sores count as herpes is worth a read.
The Bottom Line
In the valacyclovir vs acyclovir debate, there’s no dramatic winner. They’re the same active drug, delivered differently. Valacyclovir wins on convenience and has slightly better data on partner transmission. Acyclovir wins on cost and has a longer real-world track record. For most healthy adults, either choice is reasonable, and your prescriber’s pick usually reflects your dosing preferences, your kidney function, and your budget.
Talk to your pharmacist about whether switching between the two makes sense for your situation, especially if adherence or side effects have been an issue. And if you’re on daily suppressive therapy, ask specifically about once-daily valacyclovir versus twice-daily acyclovir. The difference in how often you have to think about your medication can matter more than the drug itself.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- FDA Valtrex (valacyclovir) label, official prescribing information and approved indications.
- NIH StatPearls: Valacyclovir, pharmacokinetics and bioavailability data.
- CDC STI Treatment Guidelines: Genital Herpes, first-line regimens and clinical equivalence notes.
- NEJM: Valacyclovir for the Suppression of Recurrent Genital HSV-2, landmark transmission-reduction data.
- MedlinePlus: Valacyclovir, patient-facing side-effect and safety summary.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More